サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1320204

バイオ医薬品CMO・CRO市場：製品タイプ別、ソース別、サービスタイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Biopharmaceutical CMO And CRO Market with COVID-19 Impact Analysis, By Product Type, Source, By Service Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 241 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
バイオ医薬品CMO・CRO市場：製品タイプ別、ソース別、サービスタイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 241 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バイオ医薬品CMO・CRO市場規模は2022年に324億7,830万米ドルと評価され、2023年から2030年にかけてCAGR 5.5％で拡大

バイオ医薬品CMO・CRO市場-市場力学：

バイオ医薬品産業の急成長が市場需要を促進する見込み

2020年は、主にCOVID-19パンデミックの影響により、著しい成長が見られました。バイオ医薬品業界の著名な参加者は、生産性と効率を向上させるための投資を増加させ、バイオメーカーがアウトソーシング活動に重点を移すきっかけとなっています。現在、バイオ医薬品企業は、資源や資本集約的な工程をアウトソーシングしており、場合によってはバイオ製造工程全体をアウトソーシングすることもあります。近年、バイオ医薬品業界では、事業拡大とバイオ医薬品受託製造・サービス市場での競争力維持を主な目的として、かなりの数の統合が行われています。バイオ医薬品CMO・CRO業界自体は比較的成熟しているもの、新しいバイオプロセシングツールのイントロダクション、革新的な治療薬、バイオ・医薬品業界の優先順位の変化により、バイオ医薬品受託製造業者にはさらなるプレッシャーがかかっています。その結果、CDMOは顧客や利害関係者のニーズに効果的に対応するため、さまざまなビジネスモデルを採用しています。さらに、製造施設にシングルユースシステムを組み込むことで、CMOは経済的に製造能力を拡大することができます。シングルユース製品は迅速なターンアラウンドタイムを提供し、洗浄や切り替えバリデーションなどの関連作業を軽減します。しかし、規制状況やサービスが複雑なため、CMOと顧客との契約交渉は困難な場合があります。知的財産権、保証と責任、価格設定、納期に関する問題は、顧客とCMOの双方にとって、こうした交渉をさらに複雑なものにしています。

バイオ医薬品CMO・CRO市場-主な洞察：

  • 弊社のリサーチアナリストの分析によると、世界のバイオ医薬品CMO・CRO市場は予測期間（2023-2030年）においてCAGR約5.5%で年間成長すると予測されています。
  • バイオ医薬品CMO・CRO産業は、バイオ医薬品産業の急速な成長により、高成長が予測されます。
  • ソースタイプ別では、哺乳類が2022年に最大の市場シェアを示すと予測される
  • サービスタイプ別では、受託製造が2022年の主要タイプです。
  • 地域別では、北米が2022年の主要収益源です。

バイオ医薬品CMO・CRO市場-セグメンテーション分析：

世界のバイオ医薬品CMO・CRO市場は、製品タイプ別、ソース別、サービスタイプ別、地域別に区分されます。

同市場は、ソースタイプにより、哺乳類と非哺乳類に分けられます。2022年には、哺乳類セグメントが大きな市場シェアを占めました。これは主に、業界内部の専門知識が限られており、複雑なタンパク質治療薬にヒトと同様の翻訳後修飾を導入する能力を持つ哺乳類系に企業が依存する原動力となっているためです。その他の特典として、このセグメントは、高度な発現システム、改善されたプロセスモニタリングソリューション、細胞株工学ツール、自動化されたスクリーニング方法、使い捨てデバイスの導入から大きな恩恵を受けており、その成長と成功をさらに後押ししています。

同市場は、サービスタイプによって2つのカテゴリーに分けられる：受託製造と受託研究です。2022年には、受託製造分野が最大の市場シェアを占めました。一方、予測期間中にCAGRが最も速くなると予測されているのは、調査受託セグメントです。この成長の主な要因は、バイオ医薬品企業が研究活動をアウトソーシングする傾向が強まっていることです。業界内には、バイオ医薬品企業に幅広いサービスを提供する製造受託機関（CMO）やオポチュニスティックCMOが数多く存在します。これらのサービスは、細胞の培養から始まり、充填・仕上げサービスまで、エンド・ツー・エンドをカバーしています。さらに、顧客は製品開発プログラムの製造面のアウトソーシングに積極的に投資しています。このようなアウトソーシングへの注目の高まりが、調査受託セグメントの急成長に寄与しています。

バイオ医薬品CMO・CRO市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。

バイオ医薬品CMO・CRO市場-競合情勢：

バイオ医薬品CMO・CRO市場は、多数の既存・中堅・中小規模のCMO・CROから構成されているため、断片的な構造を示しています。これらの市場参入企業の多くは非上場企業であるか、プライベート・エクイティ企業のポートフォリオに属しています。プロジェクトのスループットと製品の品質を高めるため、CMOの施設では自動化や革新的技術の導入が進んでいます。その結果、大型分子メーカーは生物製剤の需要増に対応するため、CMOとの提携に関心を高めています。

最近の動き

2023年3月、韓美薬品は2023年BIO-Europe Spring Conferenceに参加し、CMO（医薬品製造受託機関）およびCDMO（医薬品開発・製造受託機関）の事業活動を正式に開始する意向を表明しました。

研究の主な特徴

  • この調査レポートは、バイオ医薬品CMO・CRO市場の市場規模、年間平均成長率（CAGR %）、2022年を基準年とした推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、バイオ医薬品CMO・CRO市場に関する最新動向の洞察を顧客に提供します。
  • 調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、バイオ医薬品CMO・CRO市場の魅力的な投資提案マトリクスを説明します。
  • 全体的なレポートは、新規投資機会、既存企業が直面する課題、バイオ医薬品CMO・CRO市場で持続するための成長要因を特定します。
  • COVID-19のバイオ医薬品CMO・CRO市場規模、予測、CAGR、市場力学への影響については、調査対象範囲内で詳細に論じています。COVID後のバイオ医薬品CMO・CRO市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーにバイオ医薬品CMO・CRO市場の包括的な見解を提供するために、生物医薬品CMO And CRO市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいて、すべての業界セグメントをベンチマークとする成長見通しマッピング分析を網羅しています。
  • 主要市場参入企業の詳細な企業プロファイルを掲載しており、バイオ医薬品CMO・CRO市場で事業を展開する企業の財務情報や戦略的イニシアティブを理解するのに役立ちます。
  • さらに、本レポートでは、世界レベルだけでなく地域レベルでも、市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開についても明らかにしています。
  • バイオ医薬品CMO・CROの世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界のさまざまな利害関係者を対象としています。

目次

第1章 バイオ医薬品CMO・CRO市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオ医薬品CMO・CROの主要な市場動向

  • バイオ医薬品CMO・CRO市場促進要因
  • バイオ医薬品CMO・CRO市場抑制要因
  • バイオ医薬品CMO・CRO市場機会
  • バイオ医薬品CMO・CRO市場の将来動向

第4章 バイオ医薬品CMO・CRO業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 バイオ医薬品CMO・CRO市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 バイオ医薬品CMO・CRO市場情勢

  • バイオ医薬品CMO・CRO市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 バイオ医薬品CMO・CRO市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 生物製剤
    • バイオシミラー

第8章 バイオ医薬品CMO・CRO市場- ソース別

  • 概要
    • ソース別セグメントシェア分析
    • 哺乳類
    • 非哺乳類

第9章 バイオ医薬品CMO・CRO市場- サービスタイプ別

  • 概要
    • サービスタイプ別セグメントシェア分析
    • 受託製造
    • 受託調査

第10章 バイオ医薬品CMO・CRO市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米のバイオ医薬品CMO・CROの主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州のバイオ医薬品CMO・CROの主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域のバイオ医薬品CMO・CROの主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのバイオ医薬品CMO・CROの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのバイオ医薬品CMO・CROの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- バイオ医薬品CMO・CRO業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Boehringer Ingelheim GmbH
    • Lonza Group AG
    • Inno Biologics Sdn Bhd
    • Rentschler Biopharma SE
    • JRS Pharma
    • Biomeva GmbH
    • ProBioGen AG
    • Fujifilm Diosynth Biotechnologies USA, Inc.
    • Toyobo Co., Ltd.
    • Samsung Biologics
    • Thermo Fisher Scientific Inc（Patheon &PPD）
    • CMC Biologics
    • WuXi Biologics
    • AbbVie Inc.
    • Binex Co., Ltd.
    • Charles River Laboratories International, Inc.
    • ICON Plc

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biopharmaceutical CMO And CRO Market: Product type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Product type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Source 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Service Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Service Type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Biopharmaceutical CMO And CRO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product type segment market share analysis, 2022 & 2030
  • FIGURE Product type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Source segment market share analysis, 2022 & 2030
  • FIGURE Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service Type segment market share analysis, 2022 & 2030
  • FIGURE Service Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Germany Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE India Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Brazil Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1515

REPORT HIGHLIGHT

Biopharmaceutical CMO And CRO Market size was valued at USD 32,478.3 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Biopharmaceutical CMO (Contract Manufacturing Organization) and CRO (Contract Research Organization) are specialized service providers within the biopharmaceutical industry that offer outsourcing solutions to biopharmaceutical companies. These CMOs have specialized facilities and expertise to manufacture a wide range of biopharmaceuticals, including biologics, vaccines, gene therapies, and other complex biological products. Biopharmaceutical CMOs play a crucial role in the production of these advanced therapeutics, as they often require sophisticated and specialized manufacturing processes. CROs on the other hand provide research and development support, conducting various phases of preclinical and clinical trials, as well as other research activities. Biopharmaceutical CROs play a critical role in advancing the drug development process by providing expertise, resources, and infrastructure for conducting clinical trials and other research studies

Biopharmaceutical CMO And CRO Market- Market Dynamics:

Rapid growth of biopharmaceutical industry is expected to propel the market demand

The year 2020 witnessed remarkable growth, primarily attributed to the impact of the COVID-19 pandemic. Prominent participants in the biopharmaceutical industry increased their investments to improve productivity and efficiency, leading bio manufacturers to shift their focus towards outsourcing activities. Currently, biopharma companies are outsourcing resource and capital-intensive steps, and in some instances, the entire biomanufacturing process, thus driving the demand for contract-based services. In recent years, the biopharmaceutical industry has experienced a significant number of consolidations, primarily driven by the aim of expanding businesses and maintaining competitiveness in the biopharmaceutical contract manufacturing and services market. While the biopharmaceutical CMO & CRO industry itself is relatively mature, the introduction of new bioprocessing tools, innovative therapeutics, and shifting priorities in the bio/pharmaceutical industry have placed additional pressure on contract biomanufacturers. Consequently, CDMOs are adopting various business models to effectively address the needs of their clients and stakeholders. Moreover, the incorporation of single-use systems in production facilities allows CMOs to economically expand their manufacturing capacity. Single-use products offer rapid turnaround times and reduce associated tasks such as cleaning and changeover validation. However, contract negotiations between CMOs and customers can be challenging due to the complexities of the regulatory landscape and services involved. Issues related to intellectual property rights, warranties & liabilities, pricing, and timelines add further complexity to these negotiations for both clients and CMOs.

Biopharmaceutical CMO And CRO Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Biopharmaceutical CMO And CRO market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)
  • The Biopharmaceutical CMO And CRO industry is projected to grow at due to rapid growth of biopharmaceutical industry
  • Based on source type, mammalian was predicted to show maximum market share in the year 2022
  • Based on service type, Contract Manufacturing was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biopharmaceutical CMO And CRO Market- Segmentation Analysis:

The Global Biopharmaceutical CMO And CRO Market is segmented on the basis of Product Type, By Source, By Service Type, and Region.

The market is divided into two categories based on Source Type: mammalian and non- mammalian. In 2022, the mammalian segment dominated the market with a significant market share. This is mainly due to the industry's limited internal expertise, driving companies to rely on mammalian systems for their ability to introduce human-like post-translational modifications to complex protein therapeutics. Additionally, the segment has greatly benefited from the introduction of advanced expression systems, improved process monitoring solutions, cell line engineering tools, automated screening methods, and disposable devices, further bolstering its growth and success.

The market is divided into two categories based on Service type: Contract Manufacturing and Contract research. In 2022, the Contract Manufacturing segment accounted for the largest market share. On the other hand, the Contract Research segment is projected to experience the fastest CAGR during the forecast period. This growth is primarily driven by the increasing trend of biopharmaceutical companies outsourcing their research activities. Within the industry, there is a significant number of Contract Manufacturing Organizations (CMOs) and opportunistic CMOs that offer a wide array of services to biopharmaceutical entities. These services range from end-to-end coverage, starting from cell cultivation to fill/finish services. Additionally, clients are heavily investing in outsourcing the manufacturing aspect of their product development programs. This increased focus on outsourcing is contributing to the rapid growth of the Contract Research segment.

Biopharmaceutical CMO And CRO Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Biopharmaceutical CMO And CRO Market- Competitive Landscape:

The market exhibits a fragmented structure as it comprises a significant number of established and medium-to-small-sized CMOs and CROs. Many of these market participants are privately held or fall under the portfolios of private equity firms. In order to enhance project throughput and product quality, CMOs are increasingly adopting automation and innovative technologies at their facilities. As a result, large molecule manufacturers are becoming more interested in collaborating with CMOs to meet the rising demand for biologics.

Recent Developments:

In March 2023, Hanmi Pharmaceutical has announced its intention to take part in the 2023 BIO-Europe Spring Conference, where it will formally launch its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business activities.

Key features of the study:

  • This proposed research study on Biopharmaceutical CMO And CRO market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biopharmaceutical CMO And CRO market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biopharmaceutical CMO And CRO market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biopharmaceutical CMO And CRO market
  • Impact of COVID-19 on Biopharmaceutical CMO And CRO market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biopharmaceutical CMO And CRO market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biopharmaceutical CMO And CRO market, we have also included competitive landscape and key innovator analysis for the Biopharmaceutical CMO And CRO market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biopharmaceutical CMO And CRO market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biopharmaceutical CMO And CRO market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET KEY PLAYERS

  • Boehringer Ingelheim GmbH
  • Lonza Group AG
  • Inno Biologics Sdn Bhd
  • Rentschler Biopharma SE
  • JRS Pharma
  • Biomeva GmbH
  • ProBioGen AG
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Toyobo Co., Ltd.
  • Samsung Biologics
  • Thermo Fisher Scientific Inc (Patheon & PPD)
  • CMC Biologics
  • WuXi Biologics
  • AbbVie Inc.
  • Binex Co., Ltd.
  • Charles River Laboratories International, Inc.
  • ICON Plc

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY PRODUCT TYPE

  • Biologics
  • Biosimilars

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SOURCE

  • Mammalian
  • Non-mammalian

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SERVICE TYPE

  • Contract Manufacturing
  • Contract Research

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biopharmaceutical CMO And CRO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biopharmaceutical CMO And CRO Market Snippet by Product type
    • 2.1.2. Biopharmaceutical CMO And CRO Market Snippet by Source
    • 2.1.3. Biopharmaceutical CMO And CRO Market Snippet by Service Type
    • 2.1.4. Biopharmaceutical CMO And CRO Market Snippet by Country
    • 2.1.5. Biopharmaceutical CMO And CRO Market Snippet by Region
  • 2.2. Competitive Insights

3. Biopharmaceutical CMO And CRO Key Market Trends

  • 3.1. Biopharmaceutical CMO And CRO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biopharmaceutical CMO And CRO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biopharmaceutical CMO And CRO Market Opportunities
  • 3.4. Biopharmaceutical CMO And CRO Market Future Trends

4. Biopharmaceutical CMO And CRO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biopharmaceutical CMO And CRO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biopharmaceutical CMO And CRO Market Landscape

  • 6.1. Biopharmaceutical CMO And CRO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biopharmaceutical CMO And CRO Market - By Product type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product type, 2022 & 2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Biopharmaceutical CMO And CRO Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
    • 8.1.2. Mammalian
    • 8.1.3. Non-mammalian

9. Biopharmaceutical CMO And CRO Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2022 & 2030 (%)
    • 9.1.2. Contract Manufacturing
    • 9.1.3. Contract Research

10. Biopharmaceutical CMO And CRO Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biopharmaceutical CMO And CRO Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biopharmaceutical CMO And CRO Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biopharmaceutical CMO And CRO Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biopharmaceutical CMO And CRO Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biopharmaceutical CMO And CRO Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Biopharmaceutical CMO And CRO Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim GmbH
    • 11.2.2. Lonza Group AG
    • 11.2.3. Inno Biologics Sdn Bhd
    • 11.2.4. Rentschler Biopharma SE
    • 11.2.5. JRS Pharma
    • 11.2.6. Biomeva GmbH
    • 11.2.7. ProBioGen AG
    • 11.2.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    • 11.2.9. Toyobo Co., Ltd.
    • 11.2.10. Samsung Biologics
    • 11.2.11. Thermo Fisher Scientific Inc (Patheon & PPD)
    • 11.2.12. CMC Biologics
    • 11.2.13. WuXi Biologics
    • 11.2.14. AbbVie Inc.
    • 11.2.15. Binex Co., Ltd.
    • 11.2.16. Charles River Laboratories International, Inc.
    • 11.2.17. ICON Plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us